Does medical risk perception and risk taking change with age? by Hanoch, Yaniv et al.
Zurich Open Repository and
Archive
University of Zurich
Main Library
Strickhofstrasse 39
CH-8057 Zurich
www.zora.uzh.ch
Year: 2018
Does medical risk perception and risk taking change with age?
Hanoch, Yaniv; Rolison, Jonathan J; Freund, Alexandra M
Abstract: Across adulthood, people face increasingly more risky medical problems and decisions. How-
ever, little is known about changes in medical risk taking across adulthood. Therefore, the current cross-
sectional study investigated age-related differences in medical risk taking with N = 317 adults aged 20-77
years using newly developed scenarios to assess medical risk taking, and additional measures designed to
evaluate risk-taking behavior in the medical domain. Greater expected benefits on the Domain-Specific
Risk-Taking Scale-Medical (DOSPERT-M) predicted more active risk taking, whereas higher perceived
risk predicted less active risk taking. Next, we examined differences in active and passive risk taking,
where passive risk taking refers to risk taking that is associated with inaction. Age was associated with
less passive risk taking, but not with active risk taking, risk perception, or expected benefits on the
DOSPERT-M. Participants were overall more likely to opt for taking medical action than not, even more
so for a scenario about a vaccine for a deadly flu than for a scenario about a chemotherapy treatment
for cancer. Overall, participants were more likely to accept medication (vaccine or chemotherapy) for
their child than for themselves. Increasing age was associated with a lower likelihood of accepting the
treatment or vaccine for oneself. Taken together, our study provides important insights about changes
in medical risk taking across adulthood when people face an increasing number of complex and risky
medical decisions
DOI: https://doi.org/10.1111/risa.12692
Posted at the Zurich Open Repository and Archive, University of Zurich
ZORA URL: https://doi.org/10.5167/uzh-128866
Journal Article
Accepted Version
Originally published at:
Hanoch, Yaniv; Rolison, Jonathan J; Freund, Alexandra M (2018). Does medical risk perception and
risk taking change with age? Risk Analysis, 38(5):917-928.
DOI: https://doi.org/10.1111/risa.12692
Risk Analysis DOI: 10.1111/risa.12692
Does Medical Risk Perception and Risk Taking
Change with Age?
Yaniv Hanoch,1,∗ Jonathan J. Rolison,2 and Alexandra M. Freund3
Across adulthood, people face increasingly more risky medical problems and decisions. How-
ever, little is known about changes in medical risk taking across adulthood. Therefore, the
current cross-sectional study investigated age-related differences in medical risk taking with
N = 317 adults aged 20–77 years using newly developed scenarios to assess medical risk tak-
ing, and additional measures designed to evaluate risk-taking behavior in themedical domain.
Greater expected benefits on the Domain-Specific Risk-Taking Scale—Medical (DOSPERT-
M) predicted more active risk taking, whereas higher perceived risk predicted less active risk
taking. Next, we examined differences in active and passive risk taking, where passive risk
taking refers to risk taking that is associated with inaction. Age was associated with less pas-
sive risk taking, but not with active risk taking, risk perception, or expected benefits on the
DOSPERT-M. Participants were overall more likely to opt for taking medical action than
not, even more so for a scenario about a vaccine for a deadly flu than for a scenario about
a chemotherapy treatment for cancer. Overall, participants were more likely to accept med-
ication (vaccine or chemotherapy) for their child than for themselves. Increasing age was
associated with a lower likelihood of accepting the treatment or vaccine for oneself. Taken
together, our study provides important insights about changes in medical risk taking across
adulthood when people face an increasing number of complex and risky medical decisions.
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1. INTRODUCTION
Nearly half of lifetime health-related expendi-
ture incurrs in old age: the average 85-year-old in
the United States spends about $17,000 per year on
his or her health, while those in their 20s spend
less than one-tenth of that sum ($1,448).(1) One of
the reasons for the sharp increase is the rise of
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multimorbidity (i.e., multiple chronic conditions)
with age. Compared to younger adults, older adults
are far more likely to have multiple chronic diseases,
such as hypertension, heart disease, and diabetes,(2)
requiring more complex and risky decisions regard-
ing treatments and medication than single, more
short-term diseases. Thus, older adults tend to face
more costly and risky medical decisions.
1.1. Age, Risk Taking, and Risk Perception
There are surprisingly few data on how age af-
fects risk attitudes and perceptions in the medical
domain. In contrast, there is a large corpus of evi-
dence on the relation of age and financial risk taking.
The bulk of our knowledge on age-related changes
in decision making, as Mata et al.(3) demonstrated,
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has emerged from behavioral studies using finan-
cial tasks (e.g., hypothetical or actual gambles for
money). Based on analysis of 29 previous behavioral
studies, Mata et al.(3) found that age-related differ-
ences depend on the nature of the risk task, in par-
ticular, whether the decision is based on experience
or description. In tasks that involve decisions from
experience, older adults seem to be more risk seek-
ing than younger adults. In contrast, in risk tasks
that are based on description, older adults seem to
be risk averse. A large cross-cultural study,(4) which
focused on people’s attitude toward risk, revealed
that increase in age was associated with decline in
risk-taking propensity. Longitudinal data from the
German Socio-Economic Panel Study (SOEP)(5) on
both attitudes (self-report measures) and behavioral
(gambles) risk-taking propensities across the lifespan
showed that risk taking tends to diminish with age.
The authors also found positive correlations between
gambling and self-reported general risk attitude.
Overall, the above studies suggest that risk-taking
behavior depends, at least partially, on the nature of
the risk measure used. While there is a clear need to
distinguish between self-report and behavioral mea-
sures of risk taking, some evidence(6–8) indicates that
behavioral tasks are related to self-report measures,
and self-report measures are correlated with real-life
risk taking such as gambling and smoking.
One area that has not received sufficient atten-
tion in the field of aging and decision making is the
medical domain. Understanding medical risk taking
is of key importance for a number of reasons. Health
expenditure represents one of the largest percent-
ages out of the gross domestic product (GDP), with
the United States spending over 17% of its GDP
on health. Adults 65 years and over far outspend
their younger counterparts,(9) and they are signifi-
cantly more likely to suffer serious illness such as
cancer. Indeed, adults 65 years and over are three
times more likely to die from cancer (18.4 vs. 6.4
per 100,000) compared to those under 65.(9) Reduc-
ing cancer rates, thus, can not only reduce mortality
and morbidity but also reduce expenditure. A large
corpus of data has shown that risk perception is re-
lated to a range of medical-related behaviors such
as cancer screening and adherence to medication. A
study(10) of over 1,000 older adults (ages 65–89 years)
has shown that risk perception is related to colorec-
tal cancer screening. A meta-analytic review(11) re-
ported that one of the key predictors of breast can-
cer screening was women’s risk perception, and that
perceived risk was (weakly) related to age. Others(12)
have found that risk perception is associated with
males’ likelihood of undergoing genetic screening for
prostate cancer. While increasing cancer screening is
crucial, somewhat similar concerns can be found with
other medial issues. Previous research has demon-
strated that risk perception plays an important role
in patients’ perception of disease severity. A com-
prehensive review(13) has found similar trends with
regard to adherence to medication, such that higher
risk perception was associated with greater adher-
ence. Furthermore, the review pointed out the need
to better understand how patients balance risks and
benefits of medication. Taken together, understand-
ing how age affects risk attitudes and risk perception
in the medical domain has important financial and
health implications.
1.2. Risk Taking: A Question of Domain
Dating back to the early 1960s, Slovic(14) ques-
tioned the idea that studying a person’s financial
risk taking was sufficient to predict his or her risk
taking in other domains. Other researchers(15) have
provided empirical evidence to further substantiate
the idea that we need to examine more than one
risk domain, while others(16) have argued that while
a domain-specific framework is useful there is still
a scope for a general risk-taking disposition. One
study(17) found that gender differences are not consis-
tent across risk domains. They also reported that gen-
der differences in some domains result from gender
differences in risk perception (either likelihood or
severity), not risk attitude. Other work(18) examined
adult age-related differences across five different
risk-taking domains, using theDomain-Specific Risk-
Taking Scale (DOSPERT).(19) Although risk taking
in the different domains was correlated, it followed a
different age trajectory across the domains.(18) While
this study did not examine medical risk taking, the
results suggest that there was a linear decline in risk
taking (e.g., smoking and drug use) in the health do-
main across adulthood.
While this earlier study(18) provides important
data, it focused only on participants’ willingness
to engage in risky activities and did not examine
their perceived risks and expected benefits. These
two distinct constructs—perceived risks and ex-
pected benefits—are captured by the DOSPERT,
which was developed based on the idea that risk-
taking behavior is best understood by perceptions
of the risks and benefits associated with the risky
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activity.(19)4 Others(20) have argued that any discus-
sion about risk taking must incorporate the tradeoff
between the expected (or perceived) benefits and the
expected (or perceived) risks of an activity. Follow-
ing this line of reasoning, a number of studies(21,22)
have found a strong relation between perceived ben-
efits and the likelihood of engaging in risky activities.
Whether the perceived benefit plays a similar role
among older adults’ risk-taking tendencies within the
medical domain is an open question.
1.3. Omission and Commission Bias
Survey tools have been useful in gauging peo-
ple’s risk-taking attitudes, especially in trying to cap-
ture risk taking across domains. However, as age
differences in risky behavior may also depend on
the measures used to evaluate risk taking,(23) there
is a need to employ a wide spectrum of instru-
ments to evaluate risk-taking tendencies. One line of
research(24) that could further elucidate age-related
difference in risk-taking attitude is work on omis-
sion/commission bias.5 The omission/commission
bias refers to people’s willingness to accept a higher
level of risk in order to avoid being the respon-
sible agent for an action that could lead to harm.
While the omission/communion bias can be applied
to many risk domains, it has been especially useful
in the medical/health domains in shedding light on
people’s decision to accept (or reject) preventative
treatments such as vaccination. A common finding
is that people avoid immunizing themselves or their
children because “they would feel more responsible
for the death caused by the decision to vaccinate
than for the death caused by the decision to with-
hold vaccination” (p. 118).(25) However, not doing
everything in one’s power to save the life of a per-
son for whom one has assumed responsibility (e.g.,
one’s child) might be perceived as failing in the role
of a caretaker. Given the increase in generativity
across adulthood,(26) one might expect older adults to
4Interestingly, the DOSPERT risk-return framework is partially
grounded on financial risk taking. Unlike the more objective
expected value that is used in the financial domain, the risk-
return framework is seen as a subjective construct (and hence it is
termed risk attitude) that is designed to capture individuals’ per-
ceptions of the risk and benefits associated with a given activity.
5The omission/commission bias literature, however, has little to
say about possible domain differences in decisions. Nonetheless,
employing different tools to examine risk taking can provide a
more holistic picture about the relationship between age and risk
attitude.
show a stronger reversed omission bias than younger
adults when the decision concerns their child rather
than themselves.
In one illustrative study, researchers(27) asked
participants to imagine that they were either a pa-
tient, a physician treating a single patient, a medi-
cal director creating treatment guidelines, or a par-
ent deciding for a child. Participants were asked to
make treatment decisions about a vaccination against
a deadly flu and about a slow-growing cancer. Over-
all, participants were more likely to administer the
vaccine and to choose a chemotherapy treatment
when deciding for their child than when deciding for
themselves. More importantly, those aged 65 years
and older were less likely to accept the chemother-
apy treatment for themselves but more likely to ac-
cept the flu vaccine. The researcher’s(28) choice of flu
vaccination and cancer treatment could potentially
correspond to others’(3) argument that older adults
sometimes have difficulties learning from feedback
about their risk taking and, therefore, show differ-
ent decision patterns than younger adults when the
decisions are based on newly learned associations.
Applied to flu vaccinations and cancer treatments,
this would lead to different expectations regard-
ing age-related differences in risky decisions: given
the flu’s yearly occurrence, one would expect older
adults to have greater experience with flu vaccination
than younger adults because they have experienced
a greater number of flu seasons. In contrast, given
the rarity and the heterogeneity of different kinds of
cancer, young and even older adults are more likely
to have had limited (to no) experience with cancer
treatments.
The omission bias has also been linked to the sta-
tus quo bias(29)—a tendency to do nothing or main-
tain one’s current state of affairs. Inspired by these
findings, researchers(30) developed a passive risk-
taking scale to capture people’s inaction or failure
to take action in a number of risky domains. That
is, unlike other instruments, which measure a per-
son’s tendency to engage in risky actions, the passive
risk-taking scale evaluates the decision not to take
action, such as not attending a medical screening. As
age is typically associated with increased attendance
at annual medical health checks,(31) one might expect
older adults to exhibit reduced passive risk taking.
1.4. Numeracy
One factor that has gained prominent attention
in the risk-taking literature is numeracy. Referring
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to people’s ability to process and understand nu-
merical information,(32) numeracy skills also include
the capacity to evaluate risk magnitude, compare
risks, and assess risk–benefit tradeoffs.(33,34) Low nu-
meracy is associated with difficulties interpreting
risk information.(35) There is also growing evidence
that numerical ability declines with age,(18) leading,
among other things, to poorer decision making. For
example, investigators(36) reported that older adults
fared worse both on numeracy tasks and in inter-
preting medical risk and insurance information. In
a review of the numeracy literature, researchers(37)
have argued that “low numeracy distorts perceptions
of the risks and benefits of screening, reduces med-
ical compliance, impedes access to treatments, im-
pairs risk communication (limiting prevention efforts
among the most vulnerable), and . . . appears to ad-
versely affect medical outcomes” (p. 943). Building
on this research, we examined the link between age,
numeracy, and medical risk taking.
1.5. The Present Study
In the present study, our goals were (i) to ex-
amine age-related differences in medical risk taking
across adulthood; (ii) to evaluate the degree to which
medical risk-taking behavior is driven by expected
benefits and perceived risks; (iii) to study differences
in the omission/commission bias among adults of dif-
ferent ages; (iv) to investigate age-related differences
in passive risk-taking tendencies; (v) to explore how
the age of the target of the decision (own age vs.
child’s) affects medical risk-taking decisions; and to
(vi) examine the link between numeracy and risk-
taking propensity. Specifically, we predicted that age
is associated with reduced risk taking in the medical
domain.We also assumed that for all age groups, per-
ceived benefit plays a more important role in the self-
reported willingness to engage in medical risk tak-
ing than perceived risk. We hypothesized that older
adults are more willing than younger adults to vac-
cinate but not to undergo chemotherapy for cancer
treatment. We also predicted that older adults are
more likely to accept the flu vaccine and chemother-
apy for their child compared to younger adults, as a
form of reversed omission bias. We did not hold a
priori hypotheses regarding potential age-related dif-
ferences in passive risk taking.We also predicted that
high numeracy is associated with reduced risk-taking
tendencies. Finally, as earlier work has shownwomen
take fewer risks,(18,39) we also assumed that women
show lower risk-taking tendencies.
2. METHODS
2.1. Participants
The research protocol was in accordance with the
Ethics Committee at the University of Zurich. A to-
tal of 355 individuals took part in the study. How-
ever, several participants did not complete the sur-
vey, or completed it more than once. After removing
them from the analysis, a sample of N = 309 adults
aged 20–77 years (M = 48.90 years, SD = 16.48;
63% female) participated in the study. We recruited
only Mechanical Turk (MTurk) participants with a
HIT (human intelligence task) approval rate equal or
greater than 95%, and located in the United States.
On average, participants took 11.5 minutes to com-
plete the study. Concerning education, two partici-
pants had not completed secondary education, 31%
had obtained a college or bachelor’s degree, and 16%
had obtained a master’s or doctorate degree. Partici-
pants were recruited from Amazon’s MTurk and re-
ceived a token payment of U.S. $0.75.(39,40)
2.2. Materials
2.2.1. Decision Scenarios
The decision scenarios were based on those de-
veloped by Zikmund-Fisher et al.(27) Participants
read four different scenarios in which they were told
that either they or their child was in danger of a
deadly flu or had been diagnosed with a deadly, slow-
growing cancer. In the first two scenarios, partici-
pants were asked to imagine that their local area had
been sealed off due to a highly contagious and deadly
flu. They were then told that either they (Scenario 1)
or their child (Scenario 2) had a 10% chance (10 of
100 people) of dying from the flu. Next, they were in-
formed that a vaccine had been developed and tested
that would prevent them (Scenario 1) or their child
(Scenario 2) from contracting the flu with absolute
certainty. However, there was a 5% (5 of 100 peo-
ple/children) risk of dying from the vaccine. After
reading the scenarios, participants indicated whether
they would accept the vaccine for themselves
(Scenario 1) or have the vaccine administered to
their child (Scenario 2).
Scenarios 3 and 4 followed a similar design, with
the exception that participants were asked to imag-
ine that either they (Scenario 3) or their child (Sce-
nario 4) had been diagnosed with a deadly, slow-
growing cancer. They were told that if untreated,
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there was a 15% (15 of 100 people/children) risk of
dying from the cancer within five years. They were
then informed that they (or their child) had two op-
tions: Option 1 was to wait and see what will happen,
with the knowledge that there will be nothing they
can do to prevent death if the cancer spreads. The
alternative was to accept chemotherapy that would
cure them or their child with certainty, but that had
a 10% (10 of 100 people/children) risk of causing
myelodysplastic syndrome, a fictitious bone marrow
cancer that would lead to certain death within five
years. Participants indicated whether they would ac-
cept chemotherapy for themselves (Scenario 3) or
their child (Scenario 4). The order of presentation
was counterbalanced for the flu and cancer scenar-
ios, and for the options relating to themselves and to
their child.
2.2.2. DOSPERT-Medical
The DOSPERT-Medical (DOSPERT-M)(41,42)
was designed to augment the original DOSPERT19
by including six items that focus on medical proce-
dures (e.g., donating a kidney). For each item on the
DOSPERT-M, participants indicated (i) their likeli-
hood of engaging in the activity (risk taking), (ii) how
risky they perceived the activity to be (risk percep-
tion), and (iii) how much benefit they would expect
to gain from participating in the activity (risk bene-
fit). All responses were made on a seven-point scale
ranging from 1 (extremely unlikely) to 7 (extremely
likely) for the likelihood ratings, 1 (not at all risky)
to 7 (extremely risky) for the risk perception ratings,
and 1 (not beneficial at all) to 7 (extremely beneficial)
for the expected benefit ratings. The scale items indi-
cated acceptable reliability (Cronbach’s α: active risk
taking = 0.61; risk perception = 0.65; expected bene-
fits = 0.64).
2.2.3. Passive Risk-Taking Scale
Developed by Keinan and Bereby-Meyer,(29) the
questionnaire measures the tendency for passive risk
taking in three domains (resources, medical, and eth-
ical). We used only the seven-item medical domain
component of the scale for the present purposes (e.g.,
“Immediately go to the doctor’s when something in
my body is aching or bothering me”). Responses
were made on a seven-point scale ranging from 1
(very unlikely) to 7 (very likely) and were reverse
scored for the analysis. The scale items were reason-
ably reliable (Cronbach’s α = 0.65).
2.2.4. Numeracy
Participants completed the four-item objective
numeracy scale,(43) which examines individuals’ ca-
pacity to answer basic questions of probability
(Question 1: “Imagine that we roll a fair, six-sided
die 1,000 times. Out of 1,000 roles, how many times
do you think the die would come up even [2, 4,
or 6]?”; Question 2: “Imagine that we are throwing
a five-sided die 50 times. On average, out of these
50 throws how many times would this five-sided die
show an odd number [1, 3, or 5]?”) and percentages
(Question 3: In the BIG BUCKS LOTTERY, the
chances of winning a $10 prize are 1%. What is your
best guess about how many people would win a $10
prize if 1,000 people each buy a single ticket from
BIG BUCKS?”; Question 4: “In the ACME PUB-
LISHING SWEEPSTAKES, the chances of winning
a car are 1 in 1,000. What percentage of tickets of
the ACME PUBLISHING SWEEPSTAKES win a
car?”). Questions were scored as correct (coded “1”)
or incorrect (coded “0”). Total numeracy scores were
calculated by summing correct responses across the
four items (ranging from 0 to 4).
On average, participants correctly answered 1.89
(SD = 1.08; range= 0–4) of the four numeracy items.
The majority provided correct responses to Ques-
tion 1 (70%) and Question 3 (69%), whereas few re-
sponded correctly to Question 2 (19%) or Question
4 (32%).
2.3. Procedure
Participants completed the study online. Af-
ter providing informed consent, they completed the
four medical scenarios that were presented either in
the sequence of the two vaccination scenarios (self,
child) following the two cancer scenarios (self, child)
or the other way around. The decision scenarios were
followed by the DOSPERT-M, the Passive Risk-
Taking Scale, and the numeracy scale. At the end of
the survey, participants provided demographic infor-
mation.
2.4. Analytical Approach
Age-related differences in active and passive risk
taking, risk perception, and expected benefits were
tested in separate regression analyses that included
age as a continuous predictor in a first block and, to
explore nonlinear effects, a quadratic term for age
in a second block. Multiple regression analyses were
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conducted on active risk taking on the DOSPERT-M
to test for effects of risk perceptions and expected
benefits. For this analysis, age, gender, risk per-
ceptions, and expected benefits were included as
predictors in a first block. Two-way interaction terms
between each of the predictors were included in a
second block to test for moderating effects of age
and gender.
We probed fine-grained aspects of age trends in
active and passive risk taking, risk perception, and
expected benefits by calculating mean ratings for a
moving 10-year period across the entire age range.
The first period in our analysis produced the mean
scores for individuals in the 20–29-year age range.
The second period shifted by one year to include
individuals in the 21–30 year-age range. Each con-
secutive period shifted by one-year intervals (i.e.,
22–31, 23–32, and so on) until age 68–77 years. This
approach has been used to capture subtle trends
in data that can be missed by a single regression
model.(44) The smaller the period (e.g., 20–29 vs. 20–
49), the smaller the overlap across consecutive pe-
riods and so the greater the detection of subtle age
trends. We struck a balance between the size of the
period and its sample size, ensuring that the smallest
sample contained no fewer than 34 participants (min
= 34, max = 95,M = 54.63; SD = 17.20).
We used a rolling regressionmodel to probe fine-
grained aspects in the effects of risk perceptions and
expected benefits on risk taking. We employed the
same age periods used to probe age differences in
mean scores. The first regression model on risk tak-
ing, which included risk perceptions and expected
benefits as predictors, was computed for the 20–29-
year age range. The second regression model was
conducted on the 21–30-year age range, the third
model on the 22–31-year age range, the fourth on
the 23–32-year age range, the fifth on the 24–33-
year age range, and so on. Hence, the regression
model “rolled” across the age periods from youngest
to oldest, allowing us to investigate changes in the
regression coefficients across the entire age range
under study. Although adjacent age ranges in the
rolling regression overlapped considerably, the full
sequence of regressions from the youngest to oldest
age ranges can reveal subtle fluctuations in behavior
across adulthood that might be missed by a single re-
gression model.
A random effects logit model was conducted to
assess participants’ decisions to accept the flu vac-
cine and chemotherapy treatment in the medical sce-
narios. The random effects approach enabled us to
account for the clustering within our data, as all
participants responded to all types of scenarios and
questions. Scenario (chemotherapy vs. flu), question
type (child vs. self), and individual differences in age
and gender were included in a first block. In a sec-
ond block, two-way interaction terms were included
involving age and gender.
3. RESULTS
3.1. DOSPERT-M and Passive Risk-Taking Scale
Table I provides the intercorrelations between
the variables. Numeracy correlated negatively with
risk perception and positively with passive risk
taking. Higher perceived risk correlated with lower
expected benefits and active risk taking and higher
expected benefits correlated with higher active risk
taking and lower passive risk taking. Finally, higher
active risk taking was associated with lower passive
risk taking.
Our regression analysis revealed that age was
associated with less passive risk taking (linear, β =
–0.12, p = 0.04; quadratic, β = –0.13, p = 0.746) but
not active risk taking (linear, β = –0.04, p = 0.50;
quadratic, β = 0.18, p = 0.65), risk perception (linear,
β = –0.05, p = 0.37; quadratic, β = 0.29, p = 0.48),
or expected benefits (linear, β = –0.09, p = 0.13;
quadratic, β = –0.44, p = 0.28) on the DOSPERT-
M. Risk perceptions were negatively associated with
expected benefits, indicating that activities perceived
as risky were expected to yield fewer benefits. The
regression analysis revealed a moderating effect of
age on this association (β = –0.79, p < 0.01). As age
increased, the negative association between risk per-
ception and expected benefits also increased.
Fig. 1B shows the mean group ratings for a
moving 10-year period and confirms that passive
risk taking generally decreased from 20 to 29 years
(M = 4.09) to young middle adulthood (33–42 years:
M = 3.63) and from 68 to 77 years (M = 3.58),
with a jump in late middle adulthood (45–54 years:
M = 4.28) that, however, was not reflected in a
quadratic effect.
As hypothesized, greater expected benefits on
the DOSPERT-M predicted greater active risk
taking (β = 0.53, p < 0.001), whereas higher
perceived risk predicted less active risk taking
(β = –0.30, p < 0.001). Age (β = –0.01, p = 0.91) and
gender (β = 0.04, p = 0.39) were unrelated to active
risk taking (β = –0.01, p = 0.91). The second block in
Medical Risk Perception and Risk Taking 7
Table I. Pearson’s Correlations
Measure Age Numeracy Risk Perception Expected Benefits Active Risk Taking
Age –
Numeracy –0.04 –
Risk perception –0.05 –0.15* –
Expected benefits –0.09 –0.06 –0.26** –
Active risk taking –0.04 –0.06 –0.38** 0.57** –
Passive risk taking –0.12* 0.15* –0.02 –0.23** –0.26**
*p  0.05; **p  0.001.
Fig. 1. (A) Effects of risk perception and expected benefits ratings on DOSPERT-M active risk-taking ratings based on a rolling regression
with a 10-year period from age 20 to 77 years. (B) Mean group scores on the medical subscale of the Domain-Specific Risk-Taking Scale
(DOPSERT-M; active risk taking, risk perception, expected benefits) and passive risk-taking ratings for a moving average of a 10-year
period from age 20 to 77 years.
the regression analysis revealed that age moderated
the effects of risk perceptions (β = 0.55, p = 0.03) but
not expected benefits (β = 0.18, p = 0.44). Inspection
of the rolling regression analysis for a moving 10-year
period (Fig. 1A) confirms that risk perceptions influ-
enced risk taking to a lesser degree with increasing
age (β20–29 = –0.43; β68–77 = –0.23).
3.2. Decision Scenarios
Participants were more likely to opt for tak-
ing medical action (vaccine, cancer treatment) than
for inaction, even more so in the flu vaccine con-
ditions (themselves = 73%; child = 82%) than in
the chemotherapy treatment conditions (themselves
= 65%; child = 76%; Table II: Model 1). Overall,
participants were more likely to accept the treat-
ment or vaccine for their child than for themselves
(Table II: Model 1). Increasing age (Table II:
Model 1; estimated slope: 20 years = 85%; 77 years
= 63%) and being female (Table II: Model 1; men =
86%; women = 61%) were associated with a lower
likelihood of accepting the treatment or vaccine.
However, the effect of gender did not reach signif-
icance. Fig. 2 provides the estimated effects of age
and gender on acceptance across the chemotherapy
and flu scenarios. Gender interacted with scenario
(Table II: Model 2), such that gender differences
were larger for the flu scenario (male = 92%; fe-
male = 62%) than the chemotherapy scenario (male
= 81%; female = 60%; Fig. 2).
4. DISCUSSION
Given the high financial and personal costs as-
sociated with medical-related risk behavior, gaining
better insights into adult lifespan changes in medical
risk-taking tendencies and perceptions is paramount.
Using the DOSPERT-M allowed us to examine risk-
taking tendencies and perception differences in the
medical domain. Our data revealed no age-related
differences in medical risk-taking tendencies. This
result stands in contrast to the prevailing notion
that older adults are more risk averse than younger
ones.(45) Given that most empirical studies have used
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Table II. Logistic Regression Model Used to Predict Likelihood of Accepting the Treatment or Vaccine
95% CI for Odds Ratio
Included b (β) Odds Ratio Lower Upper
Model 1
Intercept scenario 2.348 (1.229)
Chemotherapy versus flu question type –0.447 (–0.224)* 0.640 0.470 0.870
Child versus self 0.615 (0.308)** 1.849 1.356 2.522
Age –0.024 (–0.387)* 0.977 0.960 0.994
Female gender –0.580 (–0.280) 0.560 0.309 1.016
Numeracy 0.075 (0.081) 1.078 0.828 1.403
Model 2
Intercept scenario 4.728 (–0.989)
Chemotherapy versus flu question type –1.435 (–0.718)* 0.238 0.077 0.741
Child versus self 0.061 (0.030) 1.063 0.348 3.245
Age –0.051 (–0.840)* 0.950 0.909 0.993
Female gender –2.079 (–1.006)* 0.125 0.027 0.575
Numeracy 0.077 (0.083) 1.080 0.826 1.413
Age × Scenario 0.006 (0.006) 1.006 0.987 1.025
Age × Question type 0.012 (0.012) 1.012 0.993 1.032
Gender × Scenario 1.022 (1.022)* 2.779 1.425 5.419
Gender × Question type –0.059 (–0.059) 0.943 0.489 1.818
The standardized coefficients (β) were calculated by standardizing the predictors such that they had a mean of 0 and a standard deviation
of 1.
*p  0.05; **p  0.001.
financial scenarios or gambling tasks to investigate
age differences in risk taking,(3) they might have pro-
vided a limited picture with regard to other domains
such as medical risk taking. In line with our findings,
there exists evidence(18) that risk taking across adult-
hood does not take a uniform shape but varies ac-
cording to domain. Our data, thus, not only high-
light the importance of focusing on a specific risk
domain(15) but also question the exclusive reliance on
financial risk taking in predicting older adults’ risk
taking in other domains.
That being said, earlier studies using the
DOSPERT-M have reported mixed results. While
one study(48) found few age-related differences,
others(49) reported heightened risk taking among
older adults. It is possible that the specific content
of the health-related questions in the DOSPERT-
M account for these differences. For example, older
adults might exhibit more altruistic tendencies, and
hence be more likely to donate blood. Indeed, in a
series of studies, researchers(50) reported that older
adults not only view contributing to the greater
good more favorably, but are more likely to act in
this manner. Furthermore, some of the questions
of the DOSPERT-M might be age specific, such as
requiring a knee replacement surgery.
In line with earlier work,(19,20) our data indicate
that risk-taking behavior can be captured by partici-
pants’ risk and benefit perception of the given activ-
ity. Indeed, in line with our hypothesis, greater ex-
pected benefit was associated with greater likelihood
of engaging in medical risk taking, and higher rat-
ing of risk perception was associated with reduced
likelihood of engaging in medical risk taking. Inter-
estingly, with increased age, risk perception played
a lesser role and perceived benefit assumed a more
prominent one. Note, however, that age was associ-
ated with a reduced focus on risk perception and not
with overvaluing the benefits.
Earlier work(30) has shown that adults over
50 years attend regular health checks and seek
health-related advice more often than their younger
counterparts. Our data provide novel support for this
pattern, indicating that older adults report reduced
passive risk-taking behavior. There are a number of
possible explanations for our findings. First, older
adults tend to experience more comorbidity, and
they might be more likely to seek out their physi-
cians when feeling unwell. In addition, many health
campaigns specifically target older individuals,(46,47)
which could help explain greater tendencies to
attend screening procedures.
Medical Risk Perception and Risk Taking 9
Fig. 2. Estimated effects of age and gender on likelihood of participants accepting the flu vaccine for (A) themselves and (B) their child
and the chemotherapy treatment for (C) themselves and (D) their child.
Ritov and Baron’s(24) work on the omission and
commission bias largely focused on young adults;
to our knowledge, few studies have examined age-
related changes in this bias. Our results reveal that
age was associated with a lower likelihood of ac-
cepting both the flu vaccine and chemotherapy treat-
ment for oneself. Furthermore, all age groups were
less likely to accept the chemotherapy compared to
the flu vaccine. Zikmund-Fisher et al.’s(27) findings
were similar: older adults were less likely to accept
chemotherapy than younger age groups. However,
their pattern of results differs from ours, as older
adults in their study had higher rates of flu vaccine ac-
ceptance. We believe that differences in experimen-
tal design—Zikmund-Fisher et al.(27) used a between-
subjects design whereas ours was a within-subjects
design—contributed to differences in the results. An-
other difference is that we changed the scenario in
a way that described a complete lock-down of the
flu-infected area to eliminate the possibility that par-
ticipants would think that, in addition to not doing
anything or accepting the vaccine, they had the third
option of leaving the area and thereby avoiding in-
fection (for themselves or their child).
Older adults’ acceptance rate of the flu vaccine in
our study closely matches real-world data, whereas
our younger sample’s acceptance of the flu vaccine
was much higher than real-world data. According
to the CDC,(47) about 67% of adults aged 65 years
and over are vaccinated. In contrast, the high rate
of younger adults who accepted the flu vaccine in
our study is much higher than reported by the CDC,
standing at about 43% for individuals aged 50–64
years and 25% for individuals aged 18–49 years. It is
possible that older adults’ greater familiarity and ex-
perience with the flu vaccine and cancer treatments
can account for our results. In other words, older
adults’ decisions on our task might have been swayed
by their personal experience, whereas the younger
participants’ decisions might have largely stemmed
from the information provided in the scenario.
With regard to gender, a systematic review(51) re-
ported that females are less likely to be vaccinated
compared to males. Our data reveal similar patterns,
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such that females were significantly less likely to ac-
cept either the flu vaccine or the cancer treatment.
Earlier studies(18) have reported that females are
more risk averse, corresponding to our results.
When examining the relationship between age
and willingness to treat one’s child, we found, as ex-
pected, that the likelihood of accepting a treatment
or vaccine was higher for all age groups for their
(hypothetical) child compared to themselves. Indeed,
our results follow earlier work(25) that also reported
higher willingness to take action when the agent
was a child rather than the participants themselves.
Furthermore, a study(52) has shown that people are
more likely to accept medical treatment for signif-
icant others than for themselves. Other findings(53)
suggest that decisions made by surrogates are often
biased toward the side of accepting. This bias might
be evenmore pronounced when the decision involves
children. Furthermore, participants’ decisions might
have been motivated by anticipated regret, as earlier
studies(54) reported that anticipated regret was the
most important predictor in decisions to vaccinate.
Counter to our expectations, numeracy levels
were unrelated to decisions about whether to accept
the flu vaccine and cancer treatment. Earlier work
has shown that more numerate individuals havemore
accurate risk perceptions,(37,55) and that accurate risk
perception is related to greater uptake of flu vac-
cine as well as mammography screening.(56) Earlier
work,(32,57) in addition, has reported a decline in nu-
meracy levels with age. Our data did not reveal sim-
ilar trends; in our study, age was not associated with
reduced numeracy ability. It is possible that older
participants onMTurk aremore numerate than those
in the general population. Also, we used only four
questions, rather than 11 in the full numeracy scale.
Using the extended numeracy scale that contains 11
questions might have produced different results.
The current study has several limitations worth
discussing. First, the study is cross-sectional, so that
the results might reflect cohort differences rather
than developmental changes. Cohort-sequential data
examining life-span changes in medical risk taking
will provide better insights into how age relates to
changes in medical risk taking. Furthermore, all
measures used in this study are based on self-reports.
Including behavioral measures of actual medical
risk taking (e.g., vaccinations) would help to further
enhance our understanding about the association of
age and medical risk taking. Moreover, we used an
MTurk-sample which, although these samples are
typically not more selected than other convenience
samples,(58) other samples (and measures) should
be used to replicate the findings and test for their
robustness.
Finally, there are a number of concerns regard-
ing the DOSPERT-M. First, previous studies did find
correlations between the DOSPERT-M and some of
the other subscales of the DOSPERT. As indicated
in Section 1, however, there is enough evidence to
question whether knowing a person’s financial risk
attitude is sufficient to predict their medical risk at-
titude. More importantly, there are some concerns
about the content validity of the DOSPERT-M, es-
pecially as it is applied to an aging population whose
medical or health needs might be changing. Indeed,
the majority of the questions in the DOSPERT-M
refer to not very risky medical procedures (giving
blood), and ones that are elective (donating a kid-
ney). None of the questions, for example, capture
the types of risky decisions that many cancer patients
face. While we acknowledge the possible limitations
of the DOSPERT-M, it is, at least at present, the
only available instrument to measure medical risk at-
titude. Indeed, we believe there is an urgent need to
develop more comprehensive and possible disease-
specific risk-taking instruments. The lack of widely
available instruments served as a partial rationale for
our inclusion of the omission/commission bias. Given
the important and difficult decisions that millions of
patients face, coupled with our aging society, there
is a clear need to develop more instruments that will
allow us to better capture patients’ attitude toward
medical risky option—in a similar way that finan-
cial institutions often gauge their clients’ risk profile
when making recommendations.
As the proportion of older adults increases in
the general population and people live longer than
ever before, complex and risky medical procedures
and treatments will become more ubiquitous. A bet-
ter understanding of how age relates to willingness
to engage in medical risk taking has clear concep-
tual and applied ramifications. It is becoming evident
that to investigate a complex phenomenon such as
medical risk taking, there is a need to employ a va-
riety of tools and measures, especially ones that fo-
cus on the medical domain and veer away from finan-
cial risk. Indeed, while financial advisors suggest that
older adults should stay away from risky financial op-
tions, it is not clear whether a similar rationale could
be applied in the medical domain and it is even less
clear whether older adults would follow such advice.
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